Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Gross Sales	$ 4,749,426	$ 4,816,444	$ 9,862,902	$ 10,192,075
Allowances	0	(439,926)	0	(440,152)
Total Net Sales	4,749,426	4,376,518	9,862,902	9,751,923
Cost of sales	1,790,062	1,795,790	3,502,929	3,613,698
Gross Profit	2,959,364	2,580,728	6,359,973	6,138,225
Operating expenses	3,445,180	4,131,719	6,932,061	8,755,053
Loss from operations	(485,816)	(1,550,991)	(572,088)	(2,616,828)
Decrease of contingent liability	0	4,828	0	74,580
Decrease (increase) in fair value of convertible debt	(2,583)	(1,446,000)	87,380	(1,446,000)
Interest expense (income)	7,642	(18,399)	19,046	(18,817)
Loss before provision for income taxes	(480,757)	(3,010,562)	(465,662)	(4,007,065)
Net Loss	(480,757)	(3,010,562)	(465,662)	(4,007,065)
Preferred dividends	1,000,500	1,000,500	2,001,001	2,001,000
Net Loss attributable to cbdMD, Inc. common shareholders	$ (1,481,257)	$ (4,011,062)	$ (2,466,663)	$ (6,008,065)
Net Loss per share:
Basic and Diluted loss per share (in dollars per share)	$ (1.9)	$ (10.84)	$ (3.67)	$ (16.23)
Weighted average number of shares Basic and Diluted: (in shares)	778,410	370,132	672,558	370,125